Cover Image

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

Objective: The aim of this analysis was to assess the safety profile of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor (SSRI) antidepressants. Methods: A pooled analysis was conducted on data obtained from the integrated safety database of edivoxetine as adjunctive tre...

Full description

Saved in:

Bibliographic Details
Main Authors:	James M Martinez (Author), Margaret B Ferguson (Author), Beth A Pangallo (Author), Tina M Oakes (Author), JonDavid Sparks (Author), Mary Anne Dellva (Author), Qi Zhang (Author), Peng Liu (Author), Mark Bangs (Author), Jonna Ahl (Author), Celine Goldberger (Author)
Format:	Book
Published:	BioExcel Publishing Ltd, 2015-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021)

Secondary and side effects of particular Selective Serotonin Reuptake Inhibitors (SSRIs) antidepressants - literature review
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2020)

A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants
by: Li J, et al.
Published: (2024)

Decreased Growth with Serotonin Reuptake Inhibitors
by: J Gordon Millichap
Published: (2002)

The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024)

Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis
by: Hanying Duan, et al.
Published: (2022)

Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection
by: Pascal Le Corre, et al.
Published: (2022)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
by: Thibault eRenoir
Published: (2013)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012)

Prenatal exposure to serotonin reuptake inhibitors: a case report
by: Solinas Agostina, et al.
Published: (2010)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
by: Thanh Thanh L. Nguyen, et al.
Published: (2021)

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
by: Patel H, et al.
Published: (2015)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
by: Jeffrey R. Strawn, et al.
Published: (2021)

New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
by: David Fanelli, et al.
Published: (2021)

A Randomized, Double-blind, Placebo - controlled Study of Safety of the Adjunctive Saffron on Sexual Dysfunction Induced by a Selective Serotonin Reuptake Inhibitor
by: P Mansoori, et al.
Published: (2011)

The Effects of Selective Serotonin-Reuptake Inhibitor on Visual Evoked Potential in Rats
by: Yoshihiro Iwamura, et al.
Published: (2004)

Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations
by: Amber N. Edinoff, et al.
Published: (2021)

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2021)

The impacts of the "4+7" pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
by: Xiaotong Wen, et al.
Published: (2022)

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
by: Ethan A. Poweleit, et al.
Published: (2022)

Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19
by: Mahsa Asadi Anar, et al.
Published: (2022)

Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?
by: Marcos Emilio Frizzo, PhD
Published: (2017)

Selective serotonin reuptake inhibitors suppress sharp wave ripples in the ventral hippocampus
by: Hiromi Shiozaki, et al.
Published: (2023)

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
by: Shin D, et al.
Published: (2017)

Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
by: Diana Dubrall, et al.
Published: (2023)

The Effect of Serotonin-Norepinephrine Reuptake Inhibitor Milnacipran on Anxiety-like Behaviors in Diabetic Mice
by: Tuhfatul Ulya, et al.
Published: (2021)

Role of selective serotonin reuptake inhibitors in prognosis dental implants: A retrospective study
by: Praveen Chandra, et al.
Published: (2021)

Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors
by: Juhee Lim, et al.
Published: (2023)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011)

LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain
by: Nannan Li, et al.
Published: (2019)

Effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, on monoamine system in mice and rats
by: Rui Xue, et al.
Published: (2016)

Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma
by: Shih-Wei Lai, et al.
Published: (2017)

Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats
by: Brunner V, et al.
Published: (2015)

The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies
by: Shih-Wei Lai, et al.
Published: (2020)

Case-Control Study Investigating the Association Between Use of Selective Serotonin Reuptake Inhibitors and Pulmonary Tuberculosis in Taiwan
by: Kao-Chi Cheng, et al.
Published: (2019)

Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort Study
by: See-Hwee Yeo, et al.
Published: (2019)

Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis
by: Wang Z, et al.
Published: (2022)

The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
by: Tony Antoniou, et al.
Published: (2022)

Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice
by: Naoki Amada, et al.
Published: (2023)